Valayer J
Département de Pédiatrie, Hôpital Bicêtre, Le Kremlin-Bicêtre.
Presse Med. 1995 Oct 21;24(31):1438-43.
The need for paediatric liver transplantation, which in most paediatric series is the remedy for biliary atresia after Kasai's operation has failed, is not sufficiently covered by organ retrieval at the present time. In most cases, survival after liver transplantation in children is approximately 80%. Mortality is still high due to intra-operative complications in most cases. Morbidity is related to vascular complications as well as to different types of infections which occur in nearly all the children. After the initial period, growth in most children returns to normal with normal physical and intellectual development. There remain a number of questions concerning the future of liver transplantation in children. What are the limits for proper indications and contraindications? What is the risk of life-long immunosuppressive treatment? Are there alternative modalities of treatment other orthotopic liver transplantation? It must be admitted that before progress has provided answers to these questions and a better understanding of the aetiology of many congenital or metabolic diseases in children as well as a better means of treatment or prevention, that the need for liver grafts in children will continue to rise as a consequence of its own success. One point must be emphasized, since we are concerned with very young children, care should always be given by specially trained health care providers.
小儿肝移植的需求目前在器官获取方面尚未得到充分满足,在大多数小儿病例系列中,肝移植是在葛西手术失败后治疗胆道闭锁的方法。在大多数情况下,儿童肝移植后的生存率约为80%。由于大多数病例存在术中并发症,死亡率仍然很高。发病率与血管并发症以及几乎所有儿童都会发生的不同类型感染有关。在初始阶段过后,大多数儿童的生长恢复正常,身体和智力发育也正常。关于儿童肝移植的未来仍有许多问题。合适的适应证和禁忌证的界限是什么?终身免疫抑制治疗的风险是什么?除了原位肝移植之外,是否有其他替代治疗方式?必须承认,在进展为这些问题提供答案、更好地理解儿童许多先天性或代谢性疾病的病因以及更好的治疗或预防手段之前,由于肝移植自身的成功,儿童对肝移植的需求将持续上升。必须强调一点,鉴于我们面对的是非常年幼的儿童,应由经过专门培训的医疗服务提供者进行护理。